Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

Screening, Confirmation and Validation of Mismatch AS F-Primers for Hypertension-Related Genotyping

Screening and validation of double allele-specific binding F-primers for the measurement of antihypertensive pharmacogenomics

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Establishment of a forward primers-superposed amplification analysis for accurate aspirin pharmacogenomic measurement

Genotyping of cytochrome P450 2D6 enzyme deficient alleles CYP2D6A and CYP2D6B by one-step ASA analysis

Sensitive detection of single-nucleotide polymorphisms by conjugated polymers for personalized treatment of hypertension

Detection of Cytochrome P450 2D6 Allele CYP2D6*6 by Using Allele-specific Amplification

Genotyping of CYP2C19 with Allele Specific Fluorescent Polymerase Chain Reaction

[Duplex Genotyping of CYP2C192 and CYP2C193 by High-Resolution Melting Curve Analysis].

A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance.

Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes

Clinical application and importance of one-step human CYP2C19 genotype detection

Development of an optimized RPA- Pf Ago detection system for MTHFR C677T polymorphism genotyping

Detection of cytochrome P4502D6 allele CYP2D6C with allele-specific amplification

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Highly specific screening of aspirin resistance-related single-nucleotide polymorphisms using ligase chain reaction strategy

Identification and Functional Assessment of Eight CYP3A4 Allelic Variants 39-46 Detected in the Chinese Han Population

[Allele specific amplification for CYP2D6 gene related to intermediate metabolizer in Chinese subjects].

A multi-AS-PCR-coupled CRISPR/Cas12a assay for the detection of ten single-base mutations

Rapid Allele-Specific PCR method for CDA 79A>C (K27Q) genotyping: A useful pharmacogenetic tool and world-wide polymorphism distribution

High-Throughput, Multiplex Genotyping Directly from Blood or Dried Blood Spot without DNA Extraction for the Screening of Multiple G6PD Gene Variants at Risk for Drug-Induced Hemolysis